CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-01 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (right to buy) | −22,890 | 306,252 | ||
| 2021-08-31 | Lee Kevin Chief Executive Officer | Option exercise | +10,420 | $14.00 | $146K | 255,505 |
| 2021-08-31 | Lee Kevin Chief Executive Officer | Sale | −9,953 | $36.23 | $361K | 245,552 |
| 2021-08-31 | Lee Kevin Chief Executive Officer | Sale | −1,272 | $37.08 | $47K | 244,280 |
| 2021-08-31 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (right to buy) | −10,420 | 329,142 | ||
| 2021-08-27 | Lee Kevin Chief Executive Officer | Option exercise | +1,808 | $14.00 | $25K | 246,893 |
| 2021-08-27 | Lee Kevin Chief Executive Officer | Sale | −1,808 | $36.02 | $65K | 245,085 |
| 2021-08-27 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (right to buy) | −1,808 | 339,562 | ||
| 2021-08-27 | Kalowski Lee President and CFO | Option exercise | +7,950 | $8.73 | $69K | 7,950 |
| 2021-08-27 | Kalowski Lee President and CFO | Sale | −7,950 | $35.15 | $279K | 0 |
| 2021-08-27 | Kalowski Lee President and CFO | Option exercise · Stock Option (Right to Buy) | −7,950 | 5,768 | ||
| 2021-08-26 | Kalowski Lee President and CFO | Option exercise | +550 | $8.76 | $5K | 550 |
| 2021-08-26 | Kalowski Lee President and CFO | Sale | −550 | $35.04 | $19K | 0 |
| 2021-08-26 | Kalowski Lee President and CFO | Option exercise · Stock Option (Right to Buy) | −550 | 13,718 | ||
| 2021-08-23 | Kalowski Lee President and CFO | Option exercise | +7,500 | $1.60 | $12K | 7,500 |
| 2021-08-23 | Kalowski Lee President and CFO | Sale | −7,500 | $33.02 | $248K | 0 |
| 2021-08-23 | Kalowski Lee President and CFO | Option exercise · Stock Option (Right to Buy) | −7,500 | 59,774 | ||
| 2021-07-29 | Kalowski Lee President and CFO | Option exercise | +12,500 | $1.63 | $20K | 12,500 |
| 2021-07-29 | Kalowski Lee President and CFO | Sale | −8,996 | $31.24 | $281K | 3,504 |
| 2021-07-29 | Kalowski Lee President and CFO | Sale | −3,204 | $32.13 | $103K | 300 |
Page 20 of 26 · 520 trades